PharmCAT: A Pharmacogenomics Clinical Annotation Tool

Teri E. Klein, Marylyn D. Ritchie

Research output: Contribution to journalComment/debate

9 Citations (Scopus)

Abstract

Implementation of genomic medicine into clinical care continues to increase in prevalence in medical centers worldwide. As defined by the National Human Genome Research Institute, “Genomic medicine is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care.…” The genomic information utilized falls broadly into two categories: 1) highly penetrant genetic disorders and 2) pharmacogenomics. Herein, we focus on pharmacogenomics, although the Pharmacogenomics Clinical Annotation Tool (PharmCAT) tool could be extended to include other types of genetic variation.

Original languageEnglish (US)
Pages (from-to)19-22
Number of pages4
JournalClinical pharmacology and therapeutics
Volume104
Issue number1
DOIs
StatePublished - Jul 2018

Fingerprint

Pharmacogenetics
National Human Genome Research Institute (U.S.)
Inborn Genetic Diseases
Clinical Medicine
Medicine

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Klein, Teri E. ; Ritchie, Marylyn D. / PharmCAT : A Pharmacogenomics Clinical Annotation Tool. In: Clinical pharmacology and therapeutics. 2018 ; Vol. 104, No. 1. pp. 19-22.
@article{bd0afcb3d3ad43dbb9451a6f55c6135d,
title = "PharmCAT: A Pharmacogenomics Clinical Annotation Tool",
abstract = "Implementation of genomic medicine into clinical care continues to increase in prevalence in medical centers worldwide. As defined by the National Human Genome Research Institute, “Genomic medicine is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care.…” The genomic information utilized falls broadly into two categories: 1) highly penetrant genetic disorders and 2) pharmacogenomics. Herein, we focus on pharmacogenomics, although the Pharmacogenomics Clinical Annotation Tool (PharmCAT) tool could be extended to include other types of genetic variation.",
author = "Klein, {Teri E.} and Ritchie, {Marylyn D.}",
year = "2018",
month = "7",
doi = "10.1002/cpt.928",
language = "English (US)",
volume = "104",
pages = "19--22",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "1",

}

PharmCAT : A Pharmacogenomics Clinical Annotation Tool. / Klein, Teri E.; Ritchie, Marylyn D.

In: Clinical pharmacology and therapeutics, Vol. 104, No. 1, 07.2018, p. 19-22.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - PharmCAT

T2 - A Pharmacogenomics Clinical Annotation Tool

AU - Klein, Teri E.

AU - Ritchie, Marylyn D.

PY - 2018/7

Y1 - 2018/7

N2 - Implementation of genomic medicine into clinical care continues to increase in prevalence in medical centers worldwide. As defined by the National Human Genome Research Institute, “Genomic medicine is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care.…” The genomic information utilized falls broadly into two categories: 1) highly penetrant genetic disorders and 2) pharmacogenomics. Herein, we focus on pharmacogenomics, although the Pharmacogenomics Clinical Annotation Tool (PharmCAT) tool could be extended to include other types of genetic variation.

AB - Implementation of genomic medicine into clinical care continues to increase in prevalence in medical centers worldwide. As defined by the National Human Genome Research Institute, “Genomic medicine is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care.…” The genomic information utilized falls broadly into two categories: 1) highly penetrant genetic disorders and 2) pharmacogenomics. Herein, we focus on pharmacogenomics, although the Pharmacogenomics Clinical Annotation Tool (PharmCAT) tool could be extended to include other types of genetic variation.

UR - http://www.scopus.com/inward/record.url?scp=85036568041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036568041&partnerID=8YFLogxK

U2 - 10.1002/cpt.928

DO - 10.1002/cpt.928

M3 - Comment/debate

C2 - 29194583

AN - SCOPUS:85036568041

VL - 104

SP - 19

EP - 22

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -